Copyright: ©Author(s) 2026.
World J Transl Med. Sep 28, 2026; 12(3): 122740
Published online Sep 28, 2026. doi: 10.5528/wjtm.122740
Published online Sep 28, 2026. doi: 10.5528/wjtm.122740
Table 1 The proportion of the 3 main short chain fatty acids in irritable bowel syndrome patients that received 60 g of the donor’s transplant
| SCFAs | Baseline | 1 month after FMF | 1 year after FMT | 2 years after FMT | 3 years after FMT |
| Acetic acid | 64 | 59 | 60 | 51 | 50 |
| Propionic acid | 19 | 18 | 18 | 16 | 17 |
| Butyric acid | 17 | 23 | 22 | 33 | 33 |
Table 2 The proportion of the 3 main short chain fatty acids in the placebo group irritable bowel syndrome patients that received their own feces
| SCFAs | Baseline | 1 month after FMF | 1 year after FMT | 2 years after FMT | 3 years after FMT |
| Acetic acid | 62 | 63 | 64 | 65 | 60 |
| Propionic acid | 22 | 19 | 18 | 20 | 23 |
| Butyric acid | 18 | 18 | 18 | 15 | 17 |
- Citation: El-Salhy M, Shin CM, Kim YS, Hatlebakk JG. Possible roles of short-chain fatty acids in the pathophysiology and treatment of irritable bowel syndrome. World J Transl Med 2026; 12(3): 122740
- URL: https://www.wjgnet.com/2220-6132/full/v12/i3/122740.htm
- DOI: https://dx.doi.org/10.5528/wjtm.122740